Medical Information

Talymus eye drops are a calcium phosphatase inhibitor used to treat dry eye syndrome, which improves ocular surface inflammation through immunomodulatory effects. Its unique mechanism can reduce the side effects of traditional hormone drugs and is suitable for patients with moderate to severe dry eye syndrome, but attention should be paid to adverse reactions such as local irritation and infection risk.

1. Mechanism of action

(1) Selective inhibition of T cell activation, blocking the production of pro-inflammatory factors such as IL-2; (2) Reduce corneal and conjunctivitis reactions, improve tear film stability; (3) Does not affect collagen synthesis and reduces the risk of corneal thinning.

2. Indicative characteristics

(1) Mainly used for moderate to severe dry eye syndrome that is ineffective or dependent on glucocorticoids; (2) Especially suitable for dry eyes with excessive evaporation accompanied by ocular surface inflammation; (3) It has potential therapeutic effects on autoimmune related dry eye syndrome, such as Sjogren's syndrome.

3. Instructions for use

(1) The standard dose is 2 times a day, 1 drop each time; (2) Shake well before medication to avoid contamination of the bottle mouth; (3) When used in combination with other eye drops, an interval of at least 10 minutes is required; (4) The treatment cycle is usually 4-12 weeks, and the efficacy needs to be evaluated regularly.

4. Adverse reaction management

(1) Common brief burning sensation (incidence 15-30%), mostly tolerable; (2) Be alert to fungal keratitis, which manifests as eye pain and photophobia; (3) Long term use may cause corneal epithelial punctate defects, requiring regular ophthalmic examinations; (4) Headache or facial flushing caused by rare systemic absorption.

5. Precautions for special populations

(1) Children need to use it under close monitoring; (2) Pregnant women weigh the pros and cons, animal experiments show embryonic toxicity; (3) Corneal transplant patients may increase the risk of infection; (4) Glaucoma patients need to monitor changes in intraocular pressure.

6. Clinical advantages

(1) Compared to cyclosporine eye drops, it takes about 2 weeks to take effect; (2) The side effects of elevated intraocular pressure without steroid drugs; (3) It has unique therapeutic effects on dry eye with meibomian gland dysfunction; (4) Can reduce the frequency of using artificial tears.